At birth, the umbilical cord is clamped, abruptly cutting off the continuous maternal glucose supply that nourished the fetus in utero. The healthy newborn must rapidly adapt by mobilizing glycogen stores and initiating gluconeogenesis to maintain stable blood sugar levels. During the first few hours of life, a temporary dip in blood glucose is entirely normal as the infant transitions to independent metabolism. Most term babies successfully stabilize within two to four hours without any intervention. However, vulnerable infants—such as those born prematurely or small for gestational age—possess severely depleted glycogen reserves and lack the mature enzymatic pathways required for quick metabolic adaptation. If these infants fail to generate alternative energy sources like ketone bodies, their developing brains face an immediate energy deficit, risking long-term neurological injury.
Neonatal hypoglycemia can present with dramatic symptoms or remain completely silent. Midwives must remain vigilant because the clinical presentation often mimics other serious neonatal conditions like birth asphyxia, sepsis, or respiratory distress syndrome.
Routine blood glucose screening is neither necessary nor recommended for healthy, term, appropriate-for-gestational-age newborns who feed well. Clinical resources must be directed toward infants whose medical histories or birth weights flag them as high-risk. Midwives should prioritize screening for:
Accurate measurement forms the bedrock of safe management. Bedside glucose meters and reagent strips provide rapid results but can be less reliable at very low ranges, prompting the need for laboratory confirmation when severe hypoglycemia is suspected. Blood samples are best obtained via a warm heel prick. Squeezing the heel too aggressively must be avoided, as tissue trauma introduces interstitial fluid and alters the glucose reading. Screening protocols typically begin within the first hour of life, repeated before subsequent feeds during the first 24 to 48 hours until metabolic stability is firmly established. Midwives should document exact numerical values rather than relying on descriptive terms, ensuring clear communication across the shift handovers.
Management depends directly on whether the infant is symptomatic and the severity of the blood sugar drop. For an asymptomatic newborn with mild hypoglycemia, early enteral feeding is the primary intervention. Breast milk or expressed colostrum should be encouraged immediately. If breastfeeding is not yet established or insufficient, calculated formula feeds serve as an effective alternative.
Oral glucose gel (40% dextrose) rubbed gently into the buccal mucosa is widely recommended for treating mild to moderate hypoglycemia in term infants, offering a rapid, non-invasive alternative to intravenous lines.
Symptomatic infants, or those with severe, refractory hypoglycemia, require immediate intravenous access. A bolus of 10% dextrose at 2 mL/kg is administered slowly over several minutes, followed immediately by a continuous infusion calculated to deliver an adequate glucose infusion rate (GIR).
Treating an acute drop in blood glucose does not complete the management cycle. Midwives must monitor the infant's response closely to ensure interventions are working. For babies receiving oral feeds or buccal gel, blood glucose should be rechecked within 30 to 60 minutes. Infants managed on intravenous dextrose require regular monitoring of their blood sugar levels, typically every two to four hours until they remain stable off intravenous support.
When discontinuing intravenous fluids, clinicians must taper the infusion rate gradually rather than stopping it abruptly. Sudden cessation of a high-glucose infusion can trigger reactive hypoglycemia because the infant's pancreas continues to pump out excess insulin, which quickly gobbles up the newly circulating glucose.